RE:'Won't find a more full pipeline for a company this size'Q-Sphera deal. couldn't get it over the line. big pharma march to own drummer
One can imagine big pharma negotiating a deal and seeing Midatech almost out of cash and desperate in the worst biotech financing market imaginable. They drag their feet waiting for Midatech to capitulate.
With the cash from the financing Midatech will be in a stronger position.
More than one company is interested I think he said.
It would be nice is soon there is a multi-product J&J license for xB3 and big pharma deal on Q-Sphera both validating the key platfrorms.
Q-Sphera works with already approved drugs so that risk is behind.
They just have to solve a formulation problem.
Depositing drug inside a tumor for time release is also being researched.
Being able to deliver a monoclonal antibody once every numbe rof months vs weeks is transformative.